1. Home
  2. CRL

CRL

Charles River Laboratories International Inc.

as 09-06-2024 4:00pm EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Commercial Physical & Biological Resarch

Nasdaq

Founded: 1947 Country:
United States
United States
Employees: N/A City: WILMINGTON
Market Cap: N/A IPO Year: 2000
Target Price: $226.27 AVG Volume (30 days): 663.6K
Analyst Decision: Buy Number of Analysts: 13
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 8.35 EPS Growth: -11.52
52 Week Low/High: $161.65 - $275.00 Next Earning Date: 08-07-2024
Revenue: $4,077,776,000 Revenue Growth: -2.41%
Revenue Growth (this year): -2.26% Revenue Growth (next year): 3.17%

CRL Daily Stock ML Predictions

Stock Insider Trading Activity of Charles River Laboratories International Inc. (CRL)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
FOSTER JAMES C CRL Chairman, President and CEO Aug 1 '24 Sell $250.00 25,000 $6,250,000.00 188,251

Share on Social Networks: